Rolnick S, LaFerla J J, Wehrle D, Trygstad E, Okagaki T
Group Health Foundation, Bloomington, Minnesota 55440-1309, USA.
Prev Med. 1996 Mar-Apr;25(2):156-61. doi: 10.1006/pmed.1996.0041.
To assess Pap smear utilization and compliance with screening recommendations, a study was conducted in a large midwestern HMO where cost is not a barrier to care. The purpose of the study was to examine rates of screening by age, identify the proportion of abnormal cytologic findings, and determine screening incidence for women with a diagnosis of cervical cancer.
Computerized records on screening frequency over a 5-year interval were examined for 23,649 consecutively enrolled women ages 18-70. In addition, medical records were examined for patients with a cervical cancer diagnosis (n = 32).
Eighty-five percent of the women had at least one Pap smear within the 5-year duration. Nearly half (47%) obtained four to five tests, 30% obtained two or three tests, and 14% were screened only once during the 5 years. Percentages were similar across all age groups. Cytopathology reports indicated 95% of tests as normal, 4% as low-grade squamous intraepithelial lesions (SIL), <1% as high-grade squamous intraepithelial lesions, and 0.02% as suspected malignancy. Younger women were more likely to evidence SIL; older women were somewhat more likely to have carcinoma. For women with a cancer diagnosis, 63% had not been screened the previous year and 34% had no screening recorded for the prior 3 years. Twenty-two percent had no record of screening within the past 5 years compared with 8.5% of the total group.
In HMOs with prepayment, one would hypothesize that patients would obtain more regular preventive screening of all types, yet women at highest risk seemed less likely to obtain Pap smear screening. This group is not fully understood and probably represents the best opportunity to reduce morbidity, mortality, and expense from preventable cervical neoplasias.
为评估巴氏涂片检查的使用情况以及对筛查建议的依从性,在中西部一家大型健康维护组织(HMO)开展了一项研究,在该组织中费用并非获得医疗服务的障碍。该研究的目的是按年龄检查筛查率,确定异常细胞学检查结果的比例,并确定诊断为宫颈癌的女性的筛查发生率。
对连续登记的23649名年龄在18至70岁之间的女性进行了为期5年的筛查频率计算机化记录检查。此外,还检查了宫颈癌诊断患者(n = 32)的病历。
85%的女性在5年期间至少进行了一次巴氏涂片检查。近一半(47%)的女性进行了四至五次检查,30%的女性进行了两至三次检查,14%的女性在这5年中仅接受了一次筛查。所有年龄组的百分比相似。细胞病理学报告显示95%的检查结果正常,4%为低级别鳞状上皮内病变(SIL),<1%为高级别鳞状上皮内病变,0.02%为疑似恶性肿瘤。年轻女性更有可能出现SIL;老年女性患癌的可能性略高。对于诊断为癌症的女性,63%在去年未进行筛查,34%在过去3年中没有筛查记录。与整个组的8.5%相比,22%的女性在过去5年中没有筛查记录。
在实行预付制的健康维护组织中,可以假设患者会更定期地进行各类预防性筛查,但风险最高的女性似乎不太可能进行巴氏涂片筛查。这一群体尚未得到充分了解,可能是降低可预防的宫颈肿瘤的发病率、死亡率和费用的最佳机会。